Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Poncin

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Revue Medicale De Liege|June 5, 2020
[Evolution of systemic anti-cancer therapies]A Poncin, G Jerusalem
Revue Medicale De Liege|June 3, 2021
[Immunotherapy for head and neck squamous cell carcinoma]M Lecocq, A Poncin, B Sautois
Journal of Immunoassay|May 11, 2000
Direct micro-radioimmunoassay of the new renin inhibitor CGP 60536G Lefévre, M Duval, A Poncin
Revue Medicale De Liege|June 3, 2021
[Immune-related adverse events]P Frères, A Poncin, M Lecocq
Revue Medicale De Liege|August 11, 2017
[Hepatosplenic lesions due to a systemic bartonellosis in an immunocompetent patient]J Narinx, A Poncin, P Huynen, et al.
Nanoscale Horizons|April 8, 2020
Nanoscale membrane architecture of healthy and pathological red blood cellsAndra C Dumitru, Mégane A Poncin, Louise Conrard, et al.
Revue Medicale De Liege|April 7, 2017
[Cancer therapy-induced cardiotoxicity]P Frères, A Poncin, M Moonen, et al.
Revue Medicale De Liege|August 20, 2015
[BREAST CANCER: FROM TARGETED THERAPY TO PRECISION MEDICINE]G Jerusalem, J Collignon, Cl Josse, et al.
Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine|June 26, 2003
Characteristics of EPI-hNE4 aerosol: a new elastase inhibitor for treatment of cystic fibrosisD Grimbert, L Vecellio, P Delépine, et al.
Protein Engineering|March 1, 1995
Second-generation octarellins: two new de novo (beta/alpha)8 polypeptides designed for investigating the influence of beta-residue packing on the alpha/beta-barrel structure stabilityA Houbrechts, B Moreau, R Abagyan, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Revue Medicale De Liege|June 5, 2020
[Evolution of systemic anti-cancer therapies]A Poncin, G Jerusalem
Revue Medicale De Liege|June 3, 2021
[Immunotherapy for head and neck squamous cell carcinoma]M Lecocq, A Poncin, B Sautois
Journal of Immunoassay|May 11, 2000
Direct micro-radioimmunoassay of the new renin inhibitor CGP 60536G Lefévre, M Duval, A Poncin
Revue Medicale De Liege|June 3, 2021
[Immune-related adverse events]P Frères, A Poncin, M Lecocq
Revue Medicale De Liege|August 11, 2017
[Hepatosplenic lesions due to a systemic bartonellosis in an immunocompetent patient]J Narinx, A Poncin, P Huynen, et al.
Nanoscale Horizons|April 8, 2020
Nanoscale membrane architecture of healthy and pathological red blood cellsAndra C Dumitru, Mégane A Poncin, Louise Conrard, et al.
Revue Medicale De Liege|April 7, 2017
[Cancer therapy-induced cardiotoxicity]P Frères, A Poncin, M Moonen, et al.
Revue Medicale De Liege|August 20, 2015
[BREAST CANCER: FROM TARGETED THERAPY TO PRECISION MEDICINE]G Jerusalem, J Collignon, Cl Josse, et al.
Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine|June 26, 2003
Characteristics of EPI-hNE4 aerosol: a new elastase inhibitor for treatment of cystic fibrosisD Grimbert, L Vecellio, P Delépine, et al.
Protein Engineering|March 1, 1995
Second-generation octarellins: two new de novo (beta/alpha)8 polypeptides designed for investigating the influence of beta-residue packing on the alpha/beta-barrel structure stabilityA Houbrechts, B Moreau, R Abagyan, et al.
Pageof 2